Cinacalcet Hydrochloride (CIN) is a new calcimimetic agent indicated for the use in hypercalcemia. The present work is aimed at development and validation of a novel and simple high-performance thin-layer chromatograp...
Guangdong Obers Blood Purification Aca demi cian Work station(2013B090400004);Guangdong University blood purifica tion technology and Engineering Re search Center(GCZX-A1104);Guangzhou en trepreneurial leader talent/LCY201215;Guangdong Provincial Center for clinical engineer ing of blood purification(507204531040)
Secondary hyperthyroidism(SHPT)is a common complication of maintenance hemodialysis(MHD).In China the prevalence of chronic kidney disease(CKD)is 10.8%and there are about 0.2 million patients treated with maintenance ...
These studies were supported by grants from the National Natural Science Foundation of China (81130010, 81470997, 31571186, and 81500545), Natural Science Foundation of Jiangsu Province (BK20150640) and Clinic Research Center of Jiangsu Province (BL2014080).
Aim: Experimental studies found that cinacalcet (ClNA) markedly attenuated vascular calcification in uremic rats, but its underlying mechanisms are still largely unknown. Recent evidence have demonstrated that endo...
Raised levels of the cardiac biomarker, Troponin I, are frequently encountered in hemodialysis patients and appear to be prognostic indicators for cardiovascular risk. Though evidence suggests that control of secondar...